Potential Wide Use for Ocuphire’s APX-3330: An Oral Drug to Prevent Diabetic Retinopathy Progression—Results of the Phase 2 ZETA-1 Trial

Mar 23, 2023

MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference

Feb 22, 2023

Top five refractive surgery items from 2022

Dec 27, 2022

Pipeline update from Ocuphire

Dec 26, 2022

Phentolamine improved distance-corrected near visual acuity

Dec 20, 2022

Treatment of Presbyopia: One of Several Potential Indications for Nyxol

Dec 1, 2022

Ocuphire partners with Viatris for marketing, commercialization of Nyxol eye drop

Nov 19, 2022

Presbyopia Physician November eUpdate

Nov 10, 2022

Ocuphire initiates Global License Agreement for Nyxol eye drops across 3 indications

Nov 8, 2022

Ocuphire reaches license agreement for the development and commercialization of Nyxol

Nov 8, 2022

• 1
• 2
• 3
• 4
• Next »